Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features-Reference-Cited by-同舟云学术

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

Published:2008-08-28 Issue:8 Volume:3 Page:e3088
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kool Marcel,Koster Jan,Bunt Jens,Hasselt Nancy E.,Lakeman Arjan,van Sluis Peter,Troost Dirk,Meeteren Netteke Schouten-van,Caron Huib N.,Cloos Jacqueline,Mršić Alan,Ylstra Bauke,Grajkowska Wieslawa,Hartmann Wolfgang,Pietsch Torsten,Ellison David,Clifford Steven C.,Versteeg Rogier

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Medulloblastoma.;F Giangaspero,2007

2. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.;J Bayani;J Neurosurg,2000

3. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization.;EM Michiels;J Pediatr Hematol Oncol,2002

4. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.;AB Hui;Clin Cancer Res,2005

5. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.;E Pan;Clin Cancer Res,2005

Cited by 602 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma;Genome Medicine;2024-08-19

2. Are the Radiological and Molecular Features of Pediatric Medulloblastomas Valuable Prognostic Indicators? A 10-Year Retrospective Review in the Middle East;World Neurosurgery;2024-07

3. Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor;Frontiers in Immunology;2024-05-28

4. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules;International Journal of Molecular Sciences;2024-03-31

5. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies;International Journal of Molecular Sciences;2024-03-29